InsidersTradesSigma
Follow the Adlai Nortye Ltd. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €922.8m. The latest transaction was disclosed on 10 June 2026 (J). Among the most active insiders: Ji Ping. All data is free.
Analysts rate Adlai Nortye Ltd. Strong Buy (bullish), based on 5 analysts. Average price target: US$28.60.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Adlai Nortye Ltd.是一家生物制药公司，专注于开发创新的癌症治疗方法。该公司在纳斯达克上市，股票代码为ADLN。